Showing 2921-2930 of 7249 results for "".
Squamoid Eccrine Ductal Carcinoma: A Diagnostic Challenge
https://practicaldermatology.com/youngmd-connect/resident-resource-center/squamoid-eccrine-ductal-carcinoma-a-diagnostic-challenge/23970/Squamoid eccrine ductal carcinoma is often initially misdiagnosed as squamous cell carcinoma.Physician Spotlight: Vishal Anil Patel, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vishal-anil-patel-md/23899/Stoking the Embers: Re-exploring Topical Coal Products
https://practicaldermatology.com/columns/clinical-focus-1/stoking-the-embers-re-exploring-topical-coal-products/23825/A Closer Look at Cibinqo for AD Management
https://practicaldermatology.com/topics/atopic-dermatitis/a-closer-look-at-cibinqo-for-ad-management/23664/Oral JAK inhibitors offer rapid onset of efficacy and some flexibility in the management of moderate to severe eczema.Slimming the Masseters with Neuromodulator Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/slimming-the-masseters-with-neuromodulator-injections/23648/Demand for this minimally-invasive and effective intervention is growing. Success depends on proper training and administration.Confronting Biases to Improve Patient Care
https://practicaldermatology.com/topics/practice-management/confronting-biases-to-improve-patient-care/23501/Cognitive biases can lead to inaccurate diagnoses and a negative impact on patient care. But it’s possible to overcome the obstacles.Aerolase’s Neo Elite 650-Microsecond 1064nm Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aerolases-neo-elite-650-microsecond-1064nm-laser/23243/A Safe, Effective Go-to Option to Treat Skin of ColorDermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of age aBenefits and Challenges of Medical Practice Types
https://practicaldermatology.com/topics/practice-management/benefits-and-challenges-of-medical-practice-types/23058/As medicine in general and dermatology specifically shifts toward more employed physicians, it’s important to understand the options.Whose Photos Are They, Anyway?
https://practicaldermatology.com/topics/practice-management/whose-photos-are-they-anyway/23032/An investigation of the complexities of using patient photos.